Advances in studies on pharmacokinetics of aristolochic acid I

Zhongguo Zhongyao Zazhi

Volumn 31, Issue 19, 2006, Pages 1573-1575

  Wang, Guan ^a,b   Wang, Zhi Min ^b   Sun, Qi Shi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Aristolochic acid I; Pharmacokinetic

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID I; LACTAM; UNCLASSIFIED DRUG;

ANIMAL; ARISTOLOCHIA; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DOSE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; KIDNEY; KIDNEY DISEASE; LIVER; MEDICINAL PLANT; METABOLISM; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; ARISTOLOCHIA; ARISTOLOCHIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; LACTAMS; LIVER; PLANTS, MEDICINAL; TISSUE DISTRIBUTION;

EID: 33947175042     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chinese source
5. Krumbiegel G, Hallensleben J, Mennicke W H. Studies on the metabolism of aristolochic I and II[J]. Xenobiotica, 1987, 17 (8):981.
6. Chinese source
7. Chinese source
8. Tanaka A, Nishida R, Maeda K, et al. Chinese herb nephropathy in Japan presents aduct onset Faconi syndrome: could different components of aristolochic acid cause a different type of Chinese herb nephropathy [J]. Clin Nephrol, 2000, 53(4):301.
9. Tanaka A, Nishida R, Yokoi H, et al. The characteristic patter of aminoaciduria in patients with aristolochic acid-induce Faconi syndrome: could aminoaciduria bethe hall mark of this syndrome [J]. Clin Nephrol, 2000, 54(3):198.
10. Chinese source